Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06646445
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-15
Brief Title:
Neoadjuvant Pembrolizumab with a Watch-and-wait Strategy for Patients with DMMRMSI-H Localized Colon Cancer GERCOR G-109 PRODIGE 84 PREMICES Phase II Trial
Sponsor:
Organization:
None